PHS Research Performance Progress Report and Other Post-award Reporting (OD)

ICR 202003-0925-004

OMB: 0925-0002

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
Unchanged
Form
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form
Unchanged
Form
Unchanged
Form
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Justification for No Material/Nonsubstantive Change
2020-03-23
Supplementary Document
2020-03-23
Supplementary Document
2020-03-23
Supplementary Document
2020-03-23
Supporting Statement A
2020-02-05
Supplementary Document
2019-12-30
Supplementary Document
2019-12-27
Supplementary Document
2019-12-27
Supplementary Document
2017-01-25
Supplementary Document
2017-01-25
Supplementary Document
2017-01-25
ICR Details
0925-0002 202003-0925-004
Historical Active 201912-0925-004
HHS/NIH 20860
PHS Research Performance Progress Report and Other Post-award Reporting (OD)
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 03/26/2020
Retrieve Notice of Action (NOA) 03/23/2020
  Inventory as of this Action Requested Previously Approved
02/28/2023 02/28/2023 02/28/2023
413,029 0 413,029
533,579 0 533,579
0 0 0

Since the last OMB approval, NIH has worked on enhancing the reporting requirements on new policies through the RPPR, which are necessary to continue enhancing the quality of basic and preclinical research, as well as NIH-funded clinical trials. The National Institutes of Health (NIH) and other Public Health Service (PHS) grantees are required to submit interim and final progress reports and other post-award documents associated with the monitoring, oversight, and closeout of an award. This 0925-0002 revision submission represents a collection of post-award reporting requirements previously collected under 0925-0002. Pre-award reporting requirements are simultaneously consolidated under 0925–0001 (expiration March 31, 2020 ) and the changes to the collection here are related. These updates fully implement the final and interim RPPR, and make updates to align with system enhancements and changes to key policies, including the requirement to submit SBIR/STTR Life Cycle Certification forms.

US Code: 42 USC 288 Name of Law: National Research Act
  
None

Not associated with rulemaking

  84 FR 14958 04/12/2019
84 FR 71965 12/30/2019
Yes

19
IC Title Form No. Form Name
iEdison 4, 5, 6, 7, 8 iEdison Burden Statement ,   iEdison Screen Shot Manage Utilization Report ,   iEdison screen shot Invention Disclosure Report ,   iEdison screen shot Patent Record ,   iEdison screen shot Registration Request Form
Trainee Diversity Report (part of RPPR) 21 Attachment 7 Trainee Diversity Report
PHS 2271 10, 9 Post-Award eRA Commons Screen Shots ,   PHS 2271
PHS 2590 15, 11, 16, 14, 12, 13 PHS 2590 Forms ,   Trainee Diversity Report ,   General Biographical Sketch Format Page ,   Fellowship Applicant Biographical Sketch Format Page ,   Fellowship Applicant Biographical Sketch Postdoctoral Sample ,   Fellowship Applicant Biographical Sketch Predoctoral Sample
Biosketch (part of RPPR) 14, 13 General Biographical Sketch Format Page ,   Fellowship Applicant Biographical Sketch Format Page
SBIR/STTR Phase II Final Progress Report 26 Final Progress Report
SBIR/STTR Life Cycle Certification 28, 27 STTR Life Cycle Certification ,   SBIR Life Cycle Certification
PHS 6031-1 2 PHS 6031-1
Trainee Diversity Report (part of Final RPPR) 21 Trainee Diversity Report
PHS Human Subjects and Clinical Trial Information (Part of RPPR, includes inclusion enrollment report) 24, 22, 23 Landing Page ,   HSCT Sections 1-6 ,   Inclusion Enrollment Report
PHS Human Subjects and Clinical Trial Information (Part of Final RPPR, includes inclusion/enrollment) 23, 24, 22 PHS Human Subjects and Clinical Trial Information- Inclusion Enrollment Report ,   PHS Human Subjects and Clinical Trial Information Sections 1-6 ,   PHS Human Subjects and Clinical Trial Information Landing Page
PHS 416-7 1, 28 National Research Service Award Termination Notice ,   Post Award eRA Commons Screen Shots xTrain, xTRACT
RPPR Core Data 17 Research Performance Progress Report (RPPR) and Final RPPR Screenshots
PHS 568 3 HHS 568
Final RPPR - Core Data 13 Research Performance Progress Report (RPPR) and Final RPPR
Data Tables (Part of RPPR) 18 Introducation to the Data Tables
Publication Reporting 19 Attachment 11 MY BIB screenshot
PHS 374 20 Attachment 18 PHS 374
Data Tables (Part of Final RPPR) 13 Research Performance Progress Report (RPPR) and Final RPPR

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 413,029 413,029 0 0 0 0
Annual Time Burden (Hours) 533,579 533,579 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
In the burden table the frequency for Publication Reporting was being calculated as 1 instead of 3 in previous submissions, as well as in the current submission. A decrease of 2,000 burden hours is due to the Final Progress Report no longer being accepted. Overall, the burden hour estimates for other PHS forms did not change.

$222,054
No
    Yes
    Yes
No
No
No
Uncollected
Tawanda Abdelmouti 240 276-5530 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/23/2020


© 2024 OMB.report | Privacy Policy